InMed Pharmaceuticals Inc. (INM)

NASDAQ: INM · IEX Real-Time Price · USD

0.235

-0.018 (-7.27%)

At close: Apr 26, 2024, 3:59 PM

0.245

+0.010 (4.39%)

After-hours: Apr 26, 2024, 4:15 PM EDT

InMed Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019
Net Income	-7.95	-18.6	-10.2	-8.94	-9.25
Depreciation & Amortization	0.6	0.51	0.23	0.2	0.12
Share-Based Compensation	0.28	0.7	0.61	0.99	2.29
Other Operating Activities	-0.21	1.81	-0.43	0.37	0.21
Operating Cash Flow	-7.28	-15.58	-9.79	-7.37	-6.62
Capital Expenditures	-0.16	-0.04	-0	-0.04	-0.03
Acquisitions	-0.5	-0.21	0	0	0
Change in Investments	0	-0.43	0	3.83	-2.06
Investing Cash Flow	-0.66	-0.67	-0	3.79	-2.09
Share Issuance / Repurchase	12	17.15	12.47	0	0.2
Debt Issued / Paid	0	-0.29	0	0	0
Other Financing Activities	-1.32	-1.78	-1.62	-0.03	-
Financing Cash Flow	10.68	15.07	10.85	-0.03	0.2
Exchange Rate Effect	0	0	0.49	-0.42	0.02
Net Cash Flow	2.74	-1.19	1.56	-4.03	-8.49
Free Cash Flow	-7.45	-15.62	-9.79	-7.42	-6.65
Free Cash Flow Margin	-180.02%	-1434.03%	-	-	-
Free Cash Flow Per Share	-3.04	-27.86	-36.43	-35.52	-32.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).